Experience

C4X Discovery Ltd

• United Kingdom
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Principal Structural Analyst

  • May 2022 - Present

• Principal Structural Analyst

  • May 2022 - Present

• Senior Structural Analyst

  • Jun 2012 - Present

  About C4X Discovery LtdC4X Discovery is a Manchester-based company focused on optimising drug discovery and design. It was founded in 2008 as a spin-out from the University of Manchester. The company uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. Since C4X Discovery's NMR technology shows what shapes active molecules prefer to adopt, it provides high-quality templates for drug discovery and design, and valuable information for drug candidate optimisation. In addition, the data is generated faster and more reliably than standard techniques such as X-ray co-crystallography or molecular modelling. C4X Discovery is using its technology in collaboration with the pharmaceutical industry and to build its own proprietary pipeline of high-value therapeutic candidates. It has been funded since inception by life science investor Aquarius Equity Partners. www.c4xdiscovery.com .



University of Queensland

• 1 - 100 Employee

• Research Officer

  • Jan 2007 - Jun 2010

  Design, synthesis and structure determination of bioactive peptides. Design, synthesis and structure determination of bioactive peptides.



Universität Hamburg

• Germany
• 1 - 100 Employee

• Doktorand

  • Aug 2001 - Sep 2006

  Method development:Saturation Transfer Difference (STD) NMR and molecular docking to determine the binding mode of ligands binding to proteins. Method development:Saturation Transfer Difference (STD) NMR and molecular docking to determine the binding mode of ligands binding to proteins.